Wednesday, November 11, 2026
22.6 C
Bengaluru

Gen Z Healthcare: Review of the Decoding Gen Z Report

Gen Z is not waiting to get sick. But are we overestimating their self-care literacy—and underestimating their contradictions? Review of the Decoding Gen Z Report by Pharmarack

The original IPM Diaries presentation makes a compelling case: Gen Z (born roughly 1997 to 2012), now comprising about 26 per cent of India’s population, is shifting healthcare from reactive, doctor-led episodes to proactive, demand-driven, continuous wellness management. Therapies like dermatology, ophthalmology, gastroenterology, and sexual wellness are seeing disproportionate growth, driven by screen time, appearance consciousness, stress, and digital-native behaviors.

But is the full picture this linear? A critical review of recent Indian and international data—from Burson, Simon-Kucher, ICICI Lombard-Kantar, McKinsey, Deloitte, and IQVIA—reveals a more nuanced, actionable reality for pharma leaders.

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

Evonile Pharma: The Real Bet Is Not the Acquisition. It is the Field Force.

ChrysCapital’s acquisition of Novartis India and its transformation into...

Closing the Value Gap in Indian Pharma: What Doctors Really Want from Digital Engagement

Indian pharma is investing heavily in digital engagement. But...

Indian Pharma 2026: The Growth Engine Is Changing

The Indian Pharmaceutical Market isn't just growing. Its centre...

Anand Shetty Appointed CEO – Emerging Markets at Cadila Pharmaceuticals

Cadila Pharmaceuticals has appointed Anand Shetty as Chief Executive...

The paradox of the “Pharmacy of the World.” đź’Š

India has world-scale formulation capability, yet the chemistry beneath...

Topics

Evonile Pharma: The Real Bet Is Not the Acquisition. It is the Field Force.

ChrysCapital’s acquisition of Novartis India and its transformation into...

Indian Pharma 2026: The Growth Engine Is Changing

The Indian Pharmaceutical Market isn't just growing. Its centre...

Anand Shetty Appointed CEO – Emerging Markets at Cadila Pharmaceuticals

Cadila Pharmaceuticals has appointed Anand Shetty as Chief Executive...

The paradox of the “Pharmacy of the World.” đź’Š

India has world-scale formulation capability, yet the chemistry beneath...

Private Equity in Indian Healthcare: Who Is Investing Beyond the Metros?

Private capital is transforming India's healthcare landscape. But is...
spot_img

Related Articles

spot_imgspot_img